Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme

BACKGROUND: The aim of the study was to assess the impact of CD133-positive (CD133+) cancer stem cell proportions on treatment results of glioblastoma multiforme (GBM) patients. PATIENTS AND METHODS: Patients with GBM (n = 42) received postoperative radiotherapy (± chemotherapy). Surgically excised...

Descripción completa

Detalles Bibliográficos
Autores principales: Kase, Marju, Minajeva, Ave, Niinepuu, Kristi, Kase, Sandra, Vardja, Markus, Asser, Toomas, Jaal, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814287/
https://www.ncbi.nlm.nih.gov/pubmed/24294187
http://dx.doi.org/10.2478/raon-2013-0055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814287/
https://www.ncbi.nlm.nih.gov/pubmed/24294187
http://dx.doi.org/10.2478/raon-2013-0055

Ejemplares similares